Kaynar, L. Et Al. 2013. Can low-dose preemptive valganciclovir replace standard intravenous ganciclovir treatment in recipients of allogeneic stem cell transplantation?. JOURNAL OF CHEMOTHERAPY , vol.25, no.5 , 286-291.

Kaynar, L., Metan, G., GÖKAHMETOĞLU, S., Kurnaz, F., Mumcuoglu, H., ÖZTÜRK, A., ... Sivgin, S.(2013). Can low-dose preemptive valganciclovir replace standard intravenous ganciclovir treatment in recipients of allogeneic stem cell transplantation?. JOURNAL OF CHEMOTHERAPY , vol.25, no.5, 286-291.

Kaynar, LEYLAGÜL Et Al. "Can low-dose preemptive valganciclovir replace standard intravenous ganciclovir treatment in recipients of allogeneic stem cell transplantation?," JOURNAL OF CHEMOTHERAPY , vol.25, no.5, 286-291, 2013

Kaynar, LEYLAGÜL Et Al. "Can low-dose preemptive valganciclovir replace standard intravenous ganciclovir treatment in recipients of allogeneic stem cell transplantation?." JOURNAL OF CHEMOTHERAPY , vol.25, no.5, pp.286-291, 2013

Kaynar, L. Et Al. (2013) . "Can low-dose preemptive valganciclovir replace standard intravenous ganciclovir treatment in recipients of allogeneic stem cell transplantation?." JOURNAL OF CHEMOTHERAPY , vol.25, no.5, pp.286-291.

@article{article, author={LEYLAGÜL KAYNAR Et Al. }, title={Can low-dose preemptive valganciclovir replace standard intravenous ganciclovir treatment in recipients of allogeneic stem cell transplantation?}, journal={JOURNAL OF CHEMOTHERAPY}, year=2013, pages={286-291} }